2 MSEK order from Linnaeus University - purchases their second Attana Cell™ 200 instrument

The Bioorganic and Biophysical Chemistry Laboratory at Linnaeus University in Kalmar headed by Prof. Ian Nicholls has ordered an Attana Cell 200 instrument. This will be their second Attana Cell 200 instrument and since previously they also have an Attana A100 instrument.

The order value is around 2 MSEK and the instrument is scheduled to be installed and invoiced prior to Midsummer. It will positively affect the result during Q2 and the cashflow during Q3.

The order is a result of a public tender and is thus complete when the time to complain has passed.

"We have successfully used the Attana instruments in both our research and education and thanks to a newly granted EU-project our need will increase further. Attana's technology enables experimental studies that has previously not been possible to perform. On top of that Attana offers top class technical and application support" says Prof. Nicholls

The research activities of the Bioorganic and Biophysical Chemistry Laboratory fall into the following areas:

1. The design, synthesis and evaluation of novel synthetic recognition systems. The study of molecular imprinting is an important aspect of our work in this area and the knowledge gained is being used for the development of mimics of enzymes and antibodies for applications in synthetic organic chemistry, biotechnology and clinical research.
2. Fundamental studies in molecular recognition involving the thermodynamic characterisation of ligand - receptor binding events.
3. The application of combinatorial chemistry and biology to the identification of new recognition elements.
4. The study of microbiological and biomacromolecular stability and viability in chemically and physically extreme environments.
5. Bionanotechnology: molecular motors. The study and application of motor protein function on micro and nano-scales.
6. The development and use of spectroscopic methods for the study of synthetic and biological recognition systems.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com 
tel: + 46 8 674 57 00

This is information that Attana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at May xx CET on xx.xx 2019

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact  sales@attana.com. 

Tags: